Replies to post #220 on Cynapsus Therapeutics Inc. (CYNA)

[Bio_pete]

I might agree with you but Dexcel Pharma was a lead investor in the secondary & now owns approximately 20% of Cynapsus. I doubt they would have committed additional funds if they felt they were going to be diluted again.